Rena Therapeutics Inc. would like to announce that the application period for the “HDO Free Trial & Collaborative Research Call 2026” officially closed on Saturday, October 31, 2026.
We extend our sincere thanks to everyone who applied. We received highly compelling proposals, which will now undergo a rigorous internal review.
Applicants will be notified of the results sequentially once the evaluation process is complete.
Thank you once again for your immense interest in this collaborative program.
We look forward to your continued support for Rena Therapeutics Inc.